Global Ocular Drug Delivery Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ocular Drug Delivery Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Ocular Drug Delivery report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ocular Drug Delivery market is projected to reach US$ 35220 million in 2034, increasing from US$ 24670 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2034. Demand from Hospitals and Ambulatory Surgical Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ocular Drug Delivery industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ocular Drug Delivery key manufacturers include OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc. OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc are top 3 players and held % sales share in total in 2022.
Ocular Drug Delivery can be divided into Ocular Insert, Iontophoresis, Intraocular Implants and In Situ Gel & Punctal Plugs, etc. Ocular Insert is the mainstream product in the market, accounting for % sales share globally in 2022.
Ocular Drug Delivery is widely used in various fields, such as Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics and Homecare Settings, etc. Hospitals provides greatest supports to the Ocular Drug Delivery industry development. In 2022, global % sales of Ocular Drug Delivery went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ocular Drug Delivery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Segment by Type
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Ocular Drug Delivery market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ocular Drug Delivery, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ocular Drug Delivery industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ocular Drug Delivery in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ocular Drug Delivery introduction, etc. Ocular Drug Delivery Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Ocular Drug Delivery market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Ocular Drug Delivery industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ocular Drug Delivery key manufacturers include OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc. OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc are top 3 players and held % sales share in total in 2022.
Ocular Drug Delivery can be divided into Ocular Insert, Iontophoresis, Intraocular Implants and In Situ Gel & Punctal Plugs, etc. Ocular Insert is the mainstream product in the market, accounting for % sales share globally in 2022.
Ocular Drug Delivery is widely used in various fields, such as Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics and Homecare Settings, etc. Hospitals provides greatest supports to the Ocular Drug Delivery industry development. In 2022, global % sales of Ocular Drug Delivery went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ocular Drug Delivery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Segment by Type
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Ocular Drug Delivery market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ocular Drug Delivery, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ocular Drug Delivery industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ocular Drug Delivery in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ocular Drug Delivery introduction, etc. Ocular Drug Delivery Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Ocular Drug Delivery market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices